Prevalence of Metabolic Syndrome and of Cardiovascular Risk Factors

1. Heinsch R. Avizul Comitetului Economic și Social European privind consecin ele îmbătrânirii popula iei asupra sistemelor de sănătate și de protec ie socială (aviz exploratoriu). Jurnalul Oficial al Uniunii Europene. 2011/C 44/02, p 10-16.Search in Google Scholar

2. Diabetes Canada Clinical Practice Guidelines Expert Committee, Punthakee Z, Goldenberg R, Katz P. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can J Diabetes. 2018;42 Suppl 1:S10-S15.10.1016/j.jcjd.2017.10.00329650080Search in Google Scholar

3. O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16(1):1-12.10.1111/obr.1222925407540Search in Google Scholar

4. Wang H, Sun Y, Yi X, Zhang L. Evaluation of the Framingham risk score and pooled cohort risk equation for prediction of cardiovascular risk in low resource areas: Insights from Asian rural population. Int J Cardiol. 2018;265:237.10.1016/j.ijcard.2018.04.06329885691Search in Google Scholar

5. Fonseca FAH, Izar MCO. Prevalence of Metabolic Syndrome and Framingham Risk Score in Vegetarian and Omnivorous Apparently Healthy Men. Arq Bras Cardiol. 2018;110(5):438-439.10.5935/abc.20180083Search in Google Scholar

6. Vanavanan S, Srisawasdi P, Rochanawutanon M, Kumproa N, Kruthkul K, Kroll MH. Performance of body mass index and percentage of body fat in predicting cardiometabolic risk factors in Thai adults. Diabetes Metab Syndr Obes. 2018;11:241-253.10.2147/DMSO.S167294598778929910627Search in Google Scholar

7. Schorr M, Dichtel LE, Gerweck AV et al. Sex differences in body composition and association with cardiometabolic risk. Biol Sex Differ. 2018;9(1):28.10.1186/s13293-018-0189-3602232829950175Search in Google Scholar

8. Cerezo C, Segura J, Praga M, Ruilope LM. Guidelines updates in the treatment of obesity or metabolic syndrome and hypertension. Curr Hypertens Rep. 2013;15(3):196-203.2351974610.1007/s11906-013-0337-423519746Search in Google Scholar

9. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112(17):2735-52.10.1161/CIRCULATIONAHA.105.16940416157765Search in Google Scholar

10. Ren Z, Zhao A, Wang Y et al. Association between Dietary Inflammatory Index, C-Reactive Protein and Metabolic Syndrome: A Cross-Sectional Study. Nutrients. 2018;10(7). pii: E831.10.3390/nu10070831607390629954070Search in Google Scholar

11. Stafeev IS, Menshikov MY, Tsokolaeva ZI, Shestakova MV, Parfyonova YV. Molecular Mechanisms of Latent Inflammation in Metabolic Syndrome. Possible Role of Sirtuins and Peroxisome Proliferator-Activated Receptor Type γ. Biochemistry (Mosc). 2015;80(10):1217-26.10.1134/S000629791510002826567565Search in Google Scholar

12. Kang JH, Song YM. Association between cotinine-verified smoking status and metabolic syndrome: analyses of Korean National Health and Nutrition Examination Surveys 2008-2010. Metab Syndr Relat Disord. 2015;13(3):140-8.10.1089/met.2014.012425621906Search in Google Scholar

13. Song YM, Chang WD, Hsu HY, Chen MD. A short-term smoking cessation may increase the risk of developing metabolic syndrome. Diabetes Metab Syndr. 2015;9(2):135-7.10.1016/j.dsx.2015.02.00525795164Search in Google Scholar

14. Riahi SM, Moamer S, Namdari M, Mokhayeri Y, Pourhoseingholi MA, Hashemi-Nazari SS. Patterns of clustering of the metabolic syndrome components and its association with coronary heart disease in the Multi-Ethnic Study of Atherosclerosis (MESA): A latent class analysis. Int J Cardiol. 2018. pii: S0167-5273(17)37027-4.Search in Google Scholar

15. Lan Y, Mai Z, Zhou S et al. Prevalence of metabolic syndrome in China: An up-dated cross-sectional study. PLoS One. 2018;13(4):e0196012.10.1371/journal.pone.0196012590601929668762Search in Google Scholar